Related Experiment Video
Updated: Nov 7, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Decreasing Trends in Antibiotic Consumption in Public Hospitals from 2014 to 2017 Following the Decentralization of
Khin Hnin Pwint1, Kyaw Soe Min2, Wenjing Tao3
1Department of Medical Research, Ministry of Health and Sports, Yangon 11191, Myanmar.
Abstract:
(1) Background: In 2014, drug procurement for public hospitals in Myanmar was decentralized to a pull system. This might lead to increasing trends in the consumption of broad-spectrum and last-resort antibiotics. For fiscal years 2014-2017, we assessed annual antibiotic consumption trends and patterns in total defined daily doses (DDDs). (2) Methods: We followed World Health Organization (WHO) methodology for surveillance of antimicrobial consumption based on hospital antibiotic procurement records (as a proxy). (3) Results: In 32% of all public hospitals where data were retrieved, total antibiotic consumption reduced by 19% between 2014 (7,122,852 DDD) and 2017 (5,794,904 DDD). Consumption per 1000 inhabitants per day (<200 bed hospitals) also reduced from 0.6 to 0.3. Over 60% of procurement was for beta-lactam antibiotics and quinolones; quinolones decreased over time. Consumption of first-line antibiotics increased (42% in 2014 to 54% in 2017), whereas broad-spectrum antibiotics decreased (46% in 2014 to 38% in 2017). Linezolid was the only last-resort antibiotic procured. There was a progressive reduction in per capita government current health expenditure from approximately 9.2 US$ in 2014 to 8.3 US$ in 2017. (4) Conclusions: Antibiotic consumption decreased over time in public hospitals. This first study provides a baseline for developing an antibiotic consumption surveillance system in Myanmar.
Insights
Myanmar
Area of Science:
- Public Health
- Pharmacoeconomics
- Infectious Disease Management
Background:
- Myanmar decentralized drug procurement to a pull system in 2014.
- This shift potentially increased broad-spectrum and last-resort antibiotic use.
- Assessing antibiotic consumption trends post-decentralization was crucial.
Purpose of the Study:
- To evaluate annual antibiotic consumption trends and patterns in Myanmar's public hospitals from 2014 to 2017.
- To establish a baseline for antimicrobial consumption surveillance.
- To analyze the impact of a decentralized drug procurement system on antibiotic use.
Main Methods:
- Utilized World Health Organization (WHO) methodology for antimicrobial consumption surveillance.
- Employed hospital antibiotic procurement records as a proxy for consumption data.
- Analyzed data in total defined daily doses (DDDs) for fiscal years 2014-2017.
Main Results:
- Total antibiotic consumption decreased by 19% across 32% of public hospitals studied (2014-2017).
- Consumption of first-line antibiotics rose, while broad-spectrum antibiotic use declined.
- Procurement of quinolones decreased; linezolid was the sole last-resort antibiotic used.
Conclusions:
- Antibiotic consumption showed a decreasing trend in Myanmar's public hospitals.
- The study provides essential baseline data for establishing a national antibiotic consumption surveillance system.
- Findings suggest a potential shift towards more judicious antibiotic prescribing patterns.
More Related Videos
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Development of Antibiotic Resistance
Antibiotic Selection
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Combined Effects of Drugs: Synergism
Such synergistic combinations...

